Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial

Japanese journal of clinical oncology, 2016-02, Vol.46 (2), p.152-162 [Peer Reviewed Journal]

The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyv181 ;PMID: 26732384

Full text available